{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:00:30Z","timestamp":1793858430915,"version":"4.6.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11001-1","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:02:24Z","timestamp":1725958944000},"page":"1794-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Narges","family":"Azizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Naghibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madjid","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Morsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedayat","family":"Abbastabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-9336","authenticated-orcid":false,"given":"Hossein","family":"Ghanaati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"11001_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R (2022) Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol 18:55\u201366","journal-title":"Nat Rev Endocrinol"},{"key":"11001_CR2","doi-asserted-by":"crossref","unstructured":"Staufer K, Stauber RE (2023) Steatotic liver disease: metabolic dysfunction, alcohol, or both? Biomedicines 11:2108","DOI":"10.3390\/biomedicines11082108"},{"key":"11001_CR3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM et al (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335\u20131347","journal-title":"Hepatology"},{"key":"11001_CR4","doi-asserted-by":"crossref","unstructured":"Han WM, Apornpong T, Lwin HMS et al (2023) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis with liver fibrosis as predictors of new-onset diabetes mellitus in people living with human immunodeficiency virus: a longitudinal cohort study. Clin Infect Dis 77:ciad433","DOI":"10.1093\/cid\/ciad433"},{"key":"11001_CR5","doi-asserted-by":"crossref","unstructured":"Tacke F, Weiskirchen R (2021) Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. Ann Transl Med 9:729","DOI":"10.21037\/atm-20-4354"},{"key":"11001_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol 70:531\u2013544","journal-title":"J Hepatol"},{"key":"11001_CR7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S (2018) Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 68:268\u2013279","journal-title":"J Hepatol"},{"key":"11001_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jceh.2018.04.001","volume":"8","author":"AJ Kovalic","year":"2018","unstructured":"Kovalic AJ, Banerjee P, Tran QT et al (2018) Genetic and epigenetic culprits in the pathogenesis of nonalcoholic fatty liver disease. J Clin Exp Hepatol 8:390\u2013402","journal-title":"J Clin Exp Hepatol"},{"key":"11001_CR9","doi-asserted-by":"crossref","first-page":"572490","DOI":"10.3389\/fendo.2020.572490","volume":"11","author":"S Della Torre","year":"2020","unstructured":"Della Torre S (2020) Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: relevance of estrogen signaling. Front Endocrinol 11:572490","journal-title":"Front Endocrinol"},{"key":"11001_CR10","doi-asserted-by":"crossref","first-page":"1047129","DOI":"10.3389\/fnut.2022.1047129","volume":"9","author":"D Wang","year":"2022","unstructured":"Wang D, Xu Y, Zhu Z et al (2022) Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: a systematic analysis of the global burden of disease study 2019. Front Nutr 9:1047129","journal-title":"Front Nutr"},{"key":"11001_CR11","doi-asserted-by":"crossref","first-page":"108389","DOI":"10.1016\/j.jdiacomp.2022.108389","volume":"37","author":"Y Handelsman","year":"2023","unstructured":"Handelsman Y, Butler J, Bakris GL et al (2023) Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications 37:108389","journal-title":"J Diabetes Complications"},{"key":"11001_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D et al (2022) American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract 28:528\u2013562","journal-title":"Endocr Pract"},{"key":"11001_CR13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082\u20131090","journal-title":"Hepatology"},{"key":"11001_CR14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","volume":"35","author":"F Bril","year":"2015","unstructured":"Bril F, Ortiz-Lopez C, Lomonaco R et al (2015) Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int 35:2139\u20132146","journal-title":"Liver Int"},{"key":"11001_CR15","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao G, Zhu S, Xiao X et al (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology 66:1486\u20131501","journal-title":"Hepatology"},{"key":"11001_CR16","doi-asserted-by":"crossref","first-page":"101167","DOI":"10.1016\/j.molmet.2021.101167","volume":"50","author":"V Ajmera","year":"2021","unstructured":"Ajmera V, Loomba R (2021) Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab 50:101167","journal-title":"Mol Metab"},{"key":"11001_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357","journal-title":"Hepatology"},{"key":"11001_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","volume":"68","author":"R Loomba","year":"2018","unstructured":"Loomba R (2018) Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions. J Hepatol 68:296\u2013304","journal-title":"J Hepatol"},{"key":"11001_CR19","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","volume":"29","author":"J Gu","year":"2019","unstructured":"Gu J, Liu S, Du S et al (2019) Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol 29:3564\u20133573","journal-title":"Eur Radiol"},{"key":"11001_CR20","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1007\/s00330-019-06071-5","volume":"29","author":"Y Qu","year":"2019","unstructured":"Qu Y, Li M, Hamilton G et al (2019) Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. Eur Radiol 29:5180\u20135189","journal-title":"Eur Radiol"},{"key":"11001_CR21","doi-asserted-by":"crossref","first-page":"e10605","DOI":"10.1097\/MD.0000000000010605","volume":"97","author":"XM Wang","year":"2018","unstructured":"Wang XM, Zhang XJ, Ma L (2018) Diagnostic performance of magnetic resonance technology in detecting steatosis or fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Medicine (Baltimore) 97:e10605","journal-title":"Medicine (Baltimore)"},{"key":"11001_CR22","volume":"9","author":"T-H Kim","year":"2019","unstructured":"Kim T-H, Jeong C-W, Jun HY et al (2019) Accuracy of proton magnetic resonance for diagnosing non-alcoholic steatohepatitis: a meta-analysis. Sci Rep 9:15002","journal-title":"Sci Rep"},{"key":"11001_CR23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336\u2013341","journal-title":"Int J Surg"},{"key":"11001_CR24","volume":"6","author":"MJ Page","year":"2017","unstructured":"Page MJ, Moher D (2017) Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) Statement and extensions: a scoping review. Syst Rev 6:263","journal-title":"Syst Rev"},{"key":"11001_CR25","first-page":"203","volume":"19","author":"AM \u0160imundi\u0107","year":"2009","unstructured":"\u0160imundi\u0107 AM (2009) Measures of diagnostic accuracy: basic definitions. EJIFCC 19:203\u2013211","journal-title":"EJIFCC"},{"key":"11001_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/apt.17564","volume":"58","author":"BK Kim","year":"2023","unstructured":"Kim BK, Bernstein N, Huang DQ et al (2023) Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Aliment Pharm Ther 58:229\u2013237","journal-title":"Aliment Pharm Ther"},{"key":"11001_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting P, Rutjes AW, Reitsma JB et al (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25","journal-title":"BMC Med Res Methodol"},{"key":"11001_CR28","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ et al (2023) Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S32\u2013s42","journal-title":"Clin Mol Hepatol"},{"key":"11001_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-2-82","volume":"2","author":"MM Leeflang","year":"2013","unstructured":"Leeflang MM, Deeks JJ, Takwoingi Y et al (2013) Cochrane diagnostic test accuracy reviews. Syst Rev 2:1\u20136","journal-title":"Syst Rev"},{"key":"11001_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1515\/CCLM.2009.317","volume":"47","author":"TJ Cleophas","year":"2009","unstructured":"Cleophas TJ, Zwinderman AH (2009) Meta-analyses of diagnostic studies. Clin Chem Lab Med 47:1351\u20131354","journal-title":"Clin Chem Lab Med"},{"key":"11001_CR31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS, Lijmer JG, Prins MH et al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129\u20131135","journal-title":"J Clin Epidemiol"},{"key":"11001_CR32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/cclm-2022-1256","volume":"61","author":"P Schlattmann","year":"2023","unstructured":"Schlattmann P (2023) Tutorial: statistical methods for the meta-analysis of diagnostic test accuracy studies. Clin Chem Lab Med 61:777\u2013794","journal-title":"Clin Chem Lab Med"},{"key":"11001_CR33","doi-asserted-by":"crossref","first-page":"e13229","DOI":"10.1111\/eci.13229","volume":"50","author":"EW Steyerberg","year":"2020","unstructured":"Steyerberg EW, Van Calster B (2020) Redefining significance and reproducibility for medical research: a plea for higher p-value thresholds for diagnostic and prognostic models. Eur J Clin Invest 50:e13229","journal-title":"Eur J Clin Invest"},{"key":"11001_CR34","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, Chichester, Chapter 9, pp 243\u2013296","DOI":"10.1002\/9780470712184"},{"key":"11001_CR35","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","DOI":"10.2307\/2533446"},{"key":"11001_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1536867X0900900203","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Whiting P (2009) Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 9:211\u2013229","journal-title":"Stata J"},{"key":"11001_CR37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178\u2013189","journal-title":"J Clin Epidemiol"},{"key":"11001_CR38","doi-asserted-by":"crossref","first-page":"20170378","DOI":"10.1259\/bjr.20170378","volume":"91","author":"BK Kang","year":"2018","unstructured":"Kang BK, Kim M, Song SY et al (2018) Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology. Br J Radiol 91:20170378","journal-title":"Br J Radiol"},{"key":"11001_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/radiol.12112520","volume":"265","author":"JP K\u00fchn","year":"2012","unstructured":"K\u00fchn JP, Hernando D, Mu\u00f1oz del Rio A et al (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265:133\u2013142","journal-title":"Radiology"},{"key":"11001_CR40","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1007\/s00330-023-09798-4","volume":"33","author":"T Orcel","year":"2023","unstructured":"Orcel T, Chau HT, Turlin B et al (2023) Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software. Eur Radiol 33:8999\u20139009","journal-title":"Eur Radiol"},{"key":"11001_CR41","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/jmri.27703","volume":"54","author":"MA Troelstra","year":"2021","unstructured":"Troelstra MA, Witjes JJ, van Dijk AM et al (2021) Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: the amsterdam NAFLD-NASH cohort. J Magn Reson Imaging 54:1937\u20131949","journal-title":"J Magn Reson Imaging"},{"key":"11001_CR42","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3348\/kjr.2022.0334","volume":"23","author":"S Park","year":"2022","unstructured":"Park S, Kwon JH, Kim SY et al (2022) Cutoff values for diagnosing hepatic steatosis using contemporary MRI-proton density fat fraction measuring methods. Korean J Radiol 23:1260\u20131268","journal-title":"Korean J Radiol"},{"key":"11001_CR43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jmri.23738","volume":"36","author":"E Joe","year":"2012","unstructured":"Joe E, Lee JM, Kim KW et al (2012) Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI. J Magn Reson Imaging 36:1124\u20131130","journal-title":"J Magn Reson Imaging"},{"key":"11001_CR44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiol.13121360","volume":"267","author":"IS Idilman","year":"2013","unstructured":"Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767\u2013775","journal-title":"Radiology"},{"key":"11001_CR45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","volume":"267","author":"A Tang","year":"2013","unstructured":"Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422\u2013431","journal-title":"Radiology"},{"key":"11001_CR46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.transproceed.2013.11.050","volume":"46","author":"HJ Chiang","year":"2014","unstructured":"Chiang HJ, Lin LH, Li CW et al (2014) Magnetic resonance fat quantification in living donor liver transplantation. Transpl Proc 46:666\u2013668","journal-title":"Transpl Proc"},{"key":"11001_CR47","doi-asserted-by":"crossref","first-page":"758164","DOI":"10.1155\/2015\/758164","volume":"2015","author":"F Paparo","year":"2015","unstructured":"Paparo F, Cenderello G, Revelli M et al (2015) Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis. Biomed Res Int 2015:758164","journal-title":"Biomed Res Int"},{"key":"11001_CR48","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/hep.27666","volume":"61","author":"JB Schwimmer","year":"2015","unstructured":"Schwimmer JB, Middleton MS, Behling C et al (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61:1887\u20131895","journal-title":"Hepatology"},{"key":"11001_CR49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","volume":"274","author":"A Tang","year":"2015","unstructured":"Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416\u2013425","journal-title":"Radiology"},{"key":"11001_CR50","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.3748\/wjg.v22.i39.8812","volume":"22","author":"M Di Martino","year":"2016","unstructured":"Di Martino M, Pacifico L, Bezzi M et al (2016) Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol 22:8812\u20138819","journal-title":"World J Gastroenterol"},{"key":"11001_CR51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0284185115580488","volume":"57","author":"IS Idilman","year":"2016","unstructured":"Idilman IS, Keskin O, Celik A et al (2016) A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol 57:271\u2013278","journal-title":"Acta Radiol"},{"key":"11001_CR52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y et al (2016) Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150:626\u2013637.e7","journal-title":"Gastroenterology"},{"key":"11001_CR53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","volume":"153","author":"MS Middleton","year":"2017","unstructured":"Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753\u2013761","journal-title":"Gastroenterology"},{"key":"11001_CR54","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.2214\/AJR.16.16726","volume":"208","author":"JS Paige","year":"2017","unstructured":"Paige JS, Bernstein GS, Heba E et al (2017) A pilot comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease. AJR Am J Roentgenol 208:W168\u2013w177","journal-title":"AJR Am J Roentgenol"},{"key":"11001_CR55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598\u2013607.e2","journal-title":"Gastroenterology"},{"key":"11001_CR56","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.29596","volume":"67","author":"MS Middleton","year":"2018","unstructured":"Middleton MS, Van Natta ML, Heba ER et al (2018) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67:858\u2013872","journal-title":"Hepatology"},{"key":"11001_CR57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00261-019-02350-3","volume":"45","author":"GM Cunha","year":"2020","unstructured":"Cunha GM, Thai TT, Hamilton G et al (2020) Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity. Abdom Radiol (NY) 45:661\u2013671","journal-title":"Abdom Radiol (NY)"},{"key":"11001_CR58","doi-asserted-by":"crossref","first-page":"e0249491","DOI":"10.1371\/journal.pone.0249491","volume":"16","author":"C Beyer","year":"2021","unstructured":"Beyer C, Hutton C, Andersson A et al (2021) Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLoS One 16:e0249491","journal-title":"PLoS One"},{"key":"11001_CR59","volume":"12","author":"A Nogami","year":"2022","unstructured":"Nogami A, Yoneda M, Iwaki M et al (2022) Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD. Sci Rep 12:21925","journal-title":"Sci Rep"},{"key":"11001_CR60","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"11001_CR61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","volume":"11","author":"EE Powell","year":"1990","unstructured":"Powell EE, Cooksley WG, Hanson R et al (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74\u201380","journal-title":"Hepatology"},{"key":"11001_CR62","first-page":"167","volume":"11","author":"F Nassir","year":"2015","unstructured":"Nassir F, Rector RS, Hammoud GM et al (2015) Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol 11:167\u2013175","journal-title":"Gastroenterol Hepatol"},{"key":"11001_CR63","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1148\/rg.296095512","volume":"29","author":"SC Faria","year":"2009","unstructured":"Faria SC, Ganesan K, Mwangi I et al (2009) MR imaging of liver fibrosis: current state of the art. Radiographics 29:1615\u20131635","journal-title":"Radiographics"},{"key":"11001_CR64","volume":"6","author":"S Qadri","year":"2024","unstructured":"Qadri S, Vartiainen E, Lahelma M et al (2024) Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: a meta-analysis. JHEP Rep 6:100928","journal-title":"JHEP Rep"},{"key":"11001_CR65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB et al (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68:763\u2013772","journal-title":"Hepatology"},{"key":"11001_CR66","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","volume":"19","author":"JG Stine","year":"2021","unstructured":"Stine JG, Munaganuru N, Barnard A et al (2021) Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 19:2274\u20132283.e5","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11001_CR67","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/modpathol.3800370","volume":"18","author":"LE Franz\u00e9n","year":"2005","unstructured":"Franz\u00e9n LE, Ekstedt M, Kechagias S et al (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18:912\u2013916","journal-title":"Mod Pathol"},{"key":"11001_CR68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.16100","volume":"53","author":"D Marti-Aguado","year":"2021","unstructured":"Marti-Aguado D, Rodr\u00edguez-Ortega A, Mestre-Alagarda C et al (2021) Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease. Aliment Pharm Ther 53:160\u2013171","journal-title":"Aliment Pharm Ther"},{"key":"11001_CR69","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898\u20131906","journal-title":"Gastroenterology"},{"key":"11001_CR70","first-page":"560","volume":"11","author":"ZM Younossi","year":"1998","unstructured":"Younossi ZM, Gramlich T, Liu YC et al (1998) Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 11:560\u2013565","journal-title":"Mod Pathol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11001-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:28:35Z","timestamp":1742203715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11001-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["11001"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11001-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"10 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Hossein Ghanaati.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (H.A.) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because we used secondary data from included studies.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because we used secondary data from included studies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}